RecruitingNCT06894303

Evaluation of Remote Programming of Cochlear Implants in Routine Cochlear Implant Follow-up


Sponsor

Advanced Bionics AG

Enrollment

51 participants

Start Date

Feb 3, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective and monocentric clinical investigation, non-interventional and non-randomized. The overall goal of this clinical study is to generate additional clinical data confirming the safety and efficacy of the remote programming functionality of Target CI version 1.5 and the AB Remote Support app. Hearing outcomes are expected to be similar whether a study subject's sound processor is programmed in the traditional method in the audiologist's office or whether programming is performed via remote fitting. Therefore, the study uses a non-inferiority design to determine whether sentence recognition in noise is no worse with remote fitting than in an in-office setting.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Target CI v1.5 remote programming for people with cochlear hearing loss. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETarget CI v1.5 remote programming

Use of the remote programming function of Target CI v1.5 and the AB remote support application


Locations(1)

Groupement Hospitalier Pitié Salpêtrière

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06894303


Related Trials